Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways.
about
ERK1/2 is a negative regulator of homeodomain protein Arix/Phox2aInfarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nervesDedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro.Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.CNTF-evoked activation of JAK and ERK mediates the functional expression of T-type Ca2+ channels in chicken nodose neurons.Cytokines inhibit norepinephrine transporter expression by decreasing Hand2Leukemia inhibitory factor regulates trafficking of T-type Ca2+ channels.Varied mechanisms of oestradiol-mediated regulation of dopamine β-hydroxylase transcriptiongp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2.gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.Ciliary neurotrophic factor stimulates tyrosine hydroxylase activity.Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injuryAngiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats.Iloperidone: a new option for the treatment of schizophrenia.Multiple promoter elements required for leukemia inhibitory factor-stimulated M2 muscarinic acetylcholine receptor promoter activity.MODULATION OF KEY BIOCHEMICAL MARKERS RELEVANT TO STROKE BY ANTIARIS AFRICANA LEAF EXTRACT FOLLOWING CEREBRAL ISCHEMIA/REPERFUSION INJURY.Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons.Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial.
P2860
Q28271778-8763A5F6-2B19-410D-A0D6-EC751604C3C0Q33803937-B53641EF-9D17-47C3-8807-6AB61F8AB293Q33877006-2BEE86D4-5DA0-4A35-B04E-15F26AFC6ED3Q33909639-6B7888F5-6806-46D8-8136-1FDF03C6B97BQ34156262-F45ACD33-49BC-452D-9228-88ECC9E50BCAQ34612857-E13C5D8A-BA9F-46BD-9323-79A53EC46161Q34717942-7DBC4FA1-709F-4AD3-A433-C2E6625F8A19Q34796339-3F4612E4-9617-480D-B7FF-A0A179616751Q35626973-7CE67F10-5741-4949-BC0E-C2BC29C8C15CQ35683496-D032CF1C-E3C1-45D9-8671-15444801A023Q35928559-C6D99923-0317-4E74-9637-D20928419BF9Q36900816-A41258BC-C718-4DEA-834F-BCA71551EB46Q37445897-76200079-DC7C-4A04-97EB-AE7A11C32B9CQ37641995-F33BE230-75C6-4E75-99AC-0570E9FEF621Q38312025-FECC7F40-75FC-43A6-A845-1FADBC50C8CCQ38714667-F5AFF4BC-5A76-4D74-9A45-07DDCF818782Q39653262-7EAAE94D-884F-4044-B389-B83D6DC16AEEQ46730789-1DFE4008-1A24-4222-A3C9-57ED63C15320
P2860
Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cytokine suppression of dopami ...... ent and -independent pathways.
@en
type
label
Cytokine suppression of dopami ...... ent and -independent pathways.
@en
prefLabel
Cytokine suppression of dopami ...... ent and -independent pathways.
@en
P2860
P356
P1476
Cytokine suppression of dopami ...... dent and -independent pathways
@en
P2093
Suzan Dziennis
P2860
P304
15897-15904
P356
10.1074/JBC.M212480200
P407
P577
2003-02-27T00:00:00Z